CardioSignal
Turku
About CardioSignal
We develop groundbreaking solutions for the detection of heart diseases. CardioSignal is a mobile application and a certified medical device for the detection of atrial fibrillation. Originally an academic spinoff, the company’s patented technology is built on a decade of research and algorithm development. CardioSignal is a brand and a product by Precordior. www.cardiosignal.com
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.2M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (May 2024)
- Website: cardiosignal.com
- Phone: +358 102 021 200
Industries & Categories
Apps, Biotechnology, Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/cardiosignal-60309 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.